The DeSci Podcast

Welcome to another episode of the DeSci Podcast! We are excited to have Nadia Asparouhova, an independent researcher and author of "Working in Public: The Making and Maintenance of Open Source Software", as our guest today. In this thought-provoking episode, we delve into the world of early-stage science funding and philanthropy. We discuss the role philanthropy plays in society and how it has evolved over the years. We also explore new funding mechanisms that have emerged to revolutionize the landscape of early-stage science, as well as the limitations and setbacks associated with these new funding mechanisms. Additionally, we discuss the political challenges of early-stage science funding and the pivotal role that government and individual patrons should play in supporting early-stage science. Please refer to the timestamps below to navigate through any of the topics discussed in the podcast. ____ ⭐ Timestamps: 00:00 Intro 01:40 The role of philanthropy. 03:16 What drove your interest in science funding? 05:00 The uniqueness of tech 06:19 Understanding early stage science 08:27 New funding mechanisms for early stage science 13:02 Limitations to the new funding mechanisms 16:09 Importance of peer review 18:25 Common misconceptions about early stage science funding 21:47 Evolution of philanthropy 27:18 Philanthropy and the government 29:35 Political Challenges of early-stage science Funding 35:25 Legitimacy in early stage science funding 41:47 Science philanthropy: Then & Now 47:23 Outro ____ If you prefer listening to podcasts on audio apps, feel free to search for "The DeSci Podcast" on Spotify, Google Podcasts & Apple Podcasts. You'll also find all links to the podcast apps below. If you want to join us on the show as a speaker or have guest ideas, please shoot us a mail at podcast@molecule.to Special thanks to: Lea Degen (host): https://twitter.com/lealeata Nadia: https://twitter.com/nayafia ____ Let's connect: Website: https://bit.ly/3d6nh2C Twitter: https://twitter.com/Molecule_dao Discord: https://discord.com/invite/moleculedao

Welcome to another episode of the DeSci Podcast. Today, we had the privilege of having Dr. Martin-Immanuel Bittner as our guest. He is the CEO of Arctoris, which is the world's first fully automated platform for drug discovery, focused on accelerating the drug discovery process. In this episode, we explore a variety of fascinating topics related to drug discovery. Dr. Bittner shares insights on the story behind building Arctoris and its mission to accelerate the drug discovery process. We also talk about how the drug development process has evolved over the years and the need to automate drug discovery research. Other topics discussed were challenges stemming from the lack of rigorous funding in biotech, common misconceptions about automation, and many more. Please feel free to navigate through any of the topics discussed in the podcast using the timestamps below. ____ ⭐ Timestamps: 0:38 Intro 1:18 About Arctoris 2:52 What drove your interests in building Arctoris 4:23 Learnings from running Arctoris 5:53 What area needs more focus 8:03 Common misconceptions about automation 10:01 Flexibility in automation 13:44 Underexploited areas 16:09 Antibiotic resistance problem 17:58 Funding structures for Biotech companies 20:15 Investing in Biotech 22:38 The private sector and Academia 25:00 Changing beliefs on the need of automation in drug discovery 27:08 Contentious issues within your field 29:06 Implicit knowledge in drug discovery ____ If you prefer listening to podcasts on audio apps, feel free to search for "The DeSci Podcast" on Spotify, Google Podcasts & Apple Podcasts. You'll also find all links to the podcast apps below. If you want to join us on the show as a speaker or have guest ideas, please shoot us a mail at podcast@molecule.to Special thanks to: Lea Degen (host): https://twitter.com/lealeata Martin: https://www.linkedin.com/in/martinimmanuelbittner/?originalSubdomain=uk ____ Let's connect: Website: https://bit.ly/3d6nh2C Twitter: https://twitter.com/Molecule_dao Discord: https://discord.com/invite/moleculedao

Martin Karlsson, CEO of Lateral, an innovative web app for scientists, discusses the best way to utilize Lateral's AI tools. We also explore the future of research, the cutting-edge capabilities of AI, and the importance of retaining human agency in the research process.

Niklas Rindtorff, co-founder of LabDAO, shares insights on conducting life science research online, benefits of collaboration within the scientific community, ownership rights in decentralized autonomous organizations, overlooked areas in decentralized science, differences in the private and public sector, and underappreciated aspects of academia.

Welcome to another episode of the DeSci Podcast. In this episode, we were joined by Dr. Emil Kendziorra and Kai Micah Mills, co-initiators of CryoDAO, a decentralized community dedicated to advancing cryopreservation research. In this podcast, we discuss the field of cryonics, including its origins and how it has evolved over the years. Dr. Emil and Mills also explain how cryopreservation works, the underexploited areas in the field of Cryonics, and how it should be Improved. We also address some of the common misconceptions about cryopreservation and recommended resources for those interested in learning more about Cryonics. Finally, our guests share their thoughts on what the future of cryonics might hold and discuss some of the most contentious topics in the field. Feel free to navigate through any of the topics discussed in the Podcast using the timestamps below. ____ ⭐ Timestamps: 0:00 Intro 1:07 Brief overview of the field of Cryonics 3:45 Origin and Evolution of Cryonics 5:51 How does Cryopreservation work? 7:00 What drove your interest in Cryonics? 10:13 Underexploited areas in Cryonics. 11:36 What is the strongest argument against Cryonics? 13:35 How public perception of Cryonics has developed over the years. 16:29 Why pets instead of humans? 18:08 Why did you become a DAO? 22:43 Areas of overlap in cryonics. 25:32 The future of Cryonics. 28:37 What is the most contentious topic in Cryonics? 30:44 Common misconceptions about cryopreservation 33:27 Resources for people interested in the field of Cryonics. 35:39 How to get involved. ____ Special thanks to: Lea Degen (host): https://twitter.com/lealeata Kai Micah Mills: https://twitter.com/kaimicahmills Dr. Emil Kendziorra: https://www.linkedin.com/in/emilkendziorra/ ____ Let's connect: Website: https://bit.ly/3d6nh2C Twitter: https://twitter.com/Molecule_dao Discord: https://discord.com/invite/moleculedao

Welcome to another episode of the DeSci Podcast. In this one, we had the pleasure of talking with Laura Minquini, who is leading AthenaDAO, a community-led movement that is improving female reproductive health through the identification, financing, and support of research projects that are working on its potential cures. We talked about Laura's story, the global panorama of the problem that she is solving, and the journey and projections of the organization that she founded and bio.xyz helped shape. Navigate through the topics discussed in this podcast using the timestamps below. ____ ⭐ Timestamps: 0:55 Intro 1:50 About Laura Minquini 8:36 About AthenaDAO 11:21 Research in Female Reproductive Health Overview 15:49 AthenaDAO structure and projects in its pipeline 23:26 AthenaDAO's first IP-NFT 26:10 Aging & Fertility 33:41 Why scientists choose to join AthenaDAO 39:44 Bio.xyz acceleration journey 43:23 Strategies to raise awareness 47:35 How to Contribute to AthenaDAO 51:34 What would happen if AthenaDAO succeeds 54:18 Outro ____ If you prefer listening to podcasts on audio apps, feel free to search for "The DeSci Podcast" on Spotify, Google Podcasts & Apple Podcasts. You'll also find all links to the podcast apps below. If you want to join us on the show as a speaker or have guest ideas, please shoot us a mail at podcast@molecule.to Special thanks to: Aastha (host): https://twitter.com/aasthajs Laura Minquini: https://twitter.com/LauraMinquini ____ Let's connect: Website: https://bit.ly/3d6nh2C Twitter: https://twitter.com/Molecule_dao Discord: https://discord.com/invite/moleculedao

Welcome to another episode of the DeSci Podcast. In this episode, we were joined by ValleyDAO's Co-founder, Albert Anis, and Communications Lead, Morgan Richards. In this video, Albert Anis and Morgan Richards provide a deep dive into the interesting field of Synthetic Biology, and the significant role that ValleyDAO plays in driving innovation in this area. We also explored the traditional funding model for Synthetic Biology and the difficulties it presents for researchers. They then emphasize the need for a new, decentralized approach to funding and the importance of collaboration in the research field. Albert and Morgan also go on to discuss the challenges of building in DeSci, and ValleyDAO's unique approach to incubating new projects, which involves providing funding, expertise, and a supportive community for researchers. Feel free to navigate through any of the topics discussed in the Podcast using the timestamps below. ____ ⭐ Timestamps: 0:40 Intro 1:18 Albert Anis’ Background 6:26 What drove your interest in Synthetic Biology? 11:19 About Valley DAO 15:33 What is Synthetic Biology? 19:58 The problem of the traditional model of funding Synthetic Biology. 24:42 What areas are ValleyDAO focused on? 31:26 ValleyDAO’s process of incubating other projects 36:23 Value of Web 3 tools to Synthetic Bio Researchers 41:20 Challenges of building in DeSci 45:50 Areas of Overlap in ValleyDAO 47:40 ValleyDAO upcoming projects 50:14 How to get involved 50:41 Outro ____ Special thanks to: Alex LaBossiere (Host): https://twitter.com/adlabossiere Albert Anis: https://twitter.com/thealbertanis Morgan Richards: https://twitter.com/Mxltiplex ____ Let's connect: Website: https://bit.ly/3d6nh2C Twitter: https://twitter.com/Molecule_dao Discord: https://discord.com/invite/moleculedao

Welcome to another episode of the DeSci Podcast. In this episode, we had the pleasure of talking with Andrew Verbinnen and Andrew Bakst from HairDAO, the second BioDAO ever to mint an IP-NFT. Their mission is to turn hair loss into a problem of the past by funding assets that they believe will accelerate its cure. Throughout the conversation, we delve into a variety of fascinating topics related to hair loss. We explore the bigger picture of this issue and highlight the crucial role of DeSci in expediting the discovery of solutions. And our guests also provide valuable insights gained from their experience in building in this ecosystem, shining a light on the HairDAO community, as well as the exciting projects that they have funded and upcoming initiatives. Navigate through the topics discussed in this podcast using the timestamps below. ____ ⭐ Timestamps: 0:23 Intro 01:08 About Andrew Verbinnen 03:01 About Andrew Bakst 04:11 Why HairDAO 05:50 Hair Loss Research & Solutions State 10:17 Hair Loss Multiphase Problem 11:57 HairDAO Community 15:05 HairDAO’s First IP-NFT 16:53 Study of Prof. Ralf Paus 19:41 Crypto & Global Cooperation 20:37 First Patient Database in DeSci 22:43 Importance of IP-NFTs 25:02 Learnings from Building a BioDAO 27:01 HairDAO Vision 27:58 HairDAO Upcoming Initatives 31:11 Outro ____ If you want to join us on the show as a speaker or have guest ideas, please shoot us a mail at podcast@molecule.to Special thanks to: Alex LaBossiere (Host): https://twitter.com/adlabossiere Andrew Verbinnen: https://twitter.com/VerbinnenAndrew Andrew Bakst: https://twitter.com/andrew_bakst ____ Let's connect: Website: https://bit.ly/3d6nh2C Twitter: https://twitter.com/Molecule_dao Discord: https://discord.com/invite/moleculedao

Welcome to this episode of the DeSci Podcast, where we dive deep into the technology behind IP-NFTs and explore the possibilities of decentralized data storage.  In this episode, Stefan Adolf, a senior web3 engineer at Molecule, and Benji Leibowitz, a former biotech venture capitalist and now a product manager at Molecule, discuss the modularity of IP-NFTs, the advantages of ERC721, 1155, and 3525 token standards. We also discuss the benefits of Arweave and IPFS for metadata and storage, Lit Protocol and unlocking data, custodial wallets and MPC providers, the SDK for developers, and the possibilities of permissionless minting and open source strategies with v2 and v3 of the IP-NFT. We hope you can learn a lot about the amazing possibilities of the decentralized tech stack and how you can build with IP-NFTs with this episode and feel free to use the timestamps below to navigate through the episode.  Navigate through the topics discussed in this podcast using the timestamps below. ____ Timestamps: 00:00 - 01:42 Intro 01:42 - 04:30 What is the IP-NFT and who should use it? 04:30 - 08:40 Token Advantages (ERC721, 1155, and 3525) 08:40 - 11:18 IP-NFT V2 (Mint-passes and Reservations) 11:18 - 12:40 Who is the ideal user for a min-pass? 12:40 - 17:24 Where is the metadata of an IP-NFT stored, and how is it structured? 17:24 - 25:19 Difference between web3 and web2 storage 25:19 - 29:21 Content gating with DAO tools 29:21 - 34:56 The role of Lit-Protocol within the IP-NFT 34:56 - 49:00 Frontend of the IP-NFTs and on web3 wallets 49:00 - 51:59 When can people start building on this technology (wen SDK?) 51:59 Outro ____ If you want to watch the Podcast on YouTube, you can find all the important links below. And if you want to join us on the show as a speaker or have guest ideas; please mail us at podcast@molecule.to linktr.ee/thedescipodcast Special thanks to:  Heinrich Tessendorf (Host): https://twitter.com/Heintess_GM Stefan Adolf: https://twitter.com/stadolf Benji Leibowitz: https://twitter.com/benjileibo ____ Let's connect: Website: https://molecule.to/ Twitter: https://twitter.com/Molecule_dao Discord: https://discord.com/invite/moleculedao

Welcome to another episode of the DeSci Podcast. In this episode, Vera Gorbunova, endowed Professor of Biology at the University of Rochester, co-director of the Rochester Aging Research Center, and co-founder of the new journal Aging Biology, run by scientists for scientists, shares with us a bit of her vast knowledge in the field of Longevity. She talked about the problems of the current scientific system, the partnership that her laboratory made with VitaDAO, and about the research that she is currently carrying out.   Navigate through the topics discussed in this podcast using the timestamps below.  ____  Timestamps:  0:42 Intro 2:53 Vera's Life Story & Background 7:44 Comparative Longevity Approach 14:12 Serendipitous Discoveries 15:34 DNA Repairing Fidelity & Epigenetics Reprogramming 24:46 Who are the heroes of Vera 27:09 What Vera strongly believes and that other people disagree 32:28 Possible Nobel Prize-winning work 35:14 Chromatin: Hallmark of Aging 39:25 HSC Stem Cells   45:20 Extracellular Matrix 50:12 VitaDAO x Vera’s Lab Partnership on Naked Mole Rats 1:00:26 Programmed vs Damage Theory of Aging 1:11:07 Issues between Scientific Journal Publishers, Editors and Reviewers 1:17:42 Potential of Decentralized Scientific Journals & Peer-review 1:32:18 Final Conclusions   ____   Special thanks to:   Sebastian Brunemeier (Host): https://twitter.com/sebastian_gero   Vera: https://www.linkedin.com/in/vera-gorbunova-64a97b46/   ____   Let's connect:   Website: https://bit.ly/3d6nh2C Twitter: https://twitter.com/Molecule_dao Discord: https://discord.com/invite/moleculedao